Literature DB >> 17283346

Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study.

Alan T Mulgrew1, Nurit Fox, Najib T Ayas, C Frank Ryan.   

Abstract

BACKGROUND: Polysomnography (PSG), despite limited availability and high cost, is currently recommended for diagnosis of obstructive sleep apnea and titration of effective continuous positive airway pressure (CPAP).
OBJECTIVE: To test the utility of a diagnostic algorithm in conjunction with ambulatory CPAP titration in initial management of obstructive sleep apnea.
DESIGN: A randomized, controlled, open-label trial that compared standard PSG with ambulatory CPAP titration in high-risk patients identified by a diagnostic algorithm.
SETTING: A tertiary referral sleep disorders program in Vancouver, British Columbia, Canada. PATIENTS: 68 patients with a high pretest probability of moderate to severe obstructive sleep apnea (apnea-hypopnea index [AHI] >15 episodes/h) identified by sequential application of the Epworth Sleepiness Scale (ESS) score, Sleep Apnea Clinical Score, and overnight oximetry. INTERVENTION: Patients were randomly assigned to PSG or ambulatory titration by using a combination of auto-CPAP and overnight oximetry. They were observed for 3 months. MEASUREMENTS: Apnea-hypopnea index on CPAP, ESS score, quality of life, and CPAP adherence.
RESULTS: The PSG and ambulatory groups had similar median BMI (38 kg/m2), age (55 years), ESS score (14 points), and respiratory disturbance index (31 episodes of respiratory disturbance/h). Each episode is determined by a computer algorithm based on analysis of oxygen saturation measured by pulse oximetry. After 3 months, there were no differences in the primary outcome, AHI on CPAP (median, 3.2 vs. 2.5; difference, 0.8/h [95% CI, -0.9 to 2.3]) (P = 0.31), between the PSG and ambulatory groups, or in the secondary outcomes, ESS score, Sleep Apnea Quality of Life Index, and CPAP. Adherence to CPAP therapy was better in the ambulatory group than in the PSG group (median, 5.4 vs. 6.0; difference, -1.12 h/night [CI, -2.0 to 0.2]) (P = 0.021).
CONCLUSIONS: In the initial management of patients with a high probability of obstructive sleep apnea, PSG confers no advantage over the ambulatory approach in terms of diagnosis and CPAP titration. The ambulatory approach may improve adherence to treatment. When access to PSG is inadequate, the ambulatory approach can be used to expedite management of patients most in need of treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17283346     DOI: 10.7326/0003-4819-146-3-200702060-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  110 in total

1.  Sleep apnea in fragile X premutation carriers with and without FXTAS.

Authors:  Alyssa Hamlin; Ying Liu; Danh V Nguyen; Flora Tassone; Lin Zhang; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-09-19       Impact factor: 3.568

2.  Ambulatory monitoring for obstructive sleep apnea: It's not the device that matters, but how the data are used.

Authors:  Frank Ryan
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

3.  Sleep medicine: the shot heard around the world.

Authors:  Meir Kryger
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

4.  "The times they are a changin:" home diagnosis of sleep apnea has arrived.

Authors:  Charles W Atwood
Journal:  Sleep       Date:  2012-06-01       Impact factor: 5.849

5.  Postal code diagnosis and treatment of sleep apnea.

Authors:  John Fleetham
Journal:  Can Respir J       Date:  2010 Jul-Aug       Impact factor: 2.409

6.  Obstructive and central sleep apnoea in Arnold-Chiari malformation: resolution following surgical decompression.

Authors:  Khoa Tran; Craig Andrew Hukins
Journal:  Sleep Breath       Date:  2010-09-12       Impact factor: 2.816

7.  Diagnostic characteristics of clinical prediction models for obstructive sleep apnea in different clinic populations.

Authors:  See-Meng Khoo; Hze-Khoong Poh; Yiong-Huak Chan; Wang-Jee Ngerng; Dong-Xia Shi; T K Lim
Journal:  Sleep Breath       Date:  2010-05-04       Impact factor: 2.816

8.  Canadian Sleep Society/Canadian Thoracic Society position paper on the use of portable monitoring for the diagnosis of obstructive sleep apnea/hypopnea in adults.

Authors:  Adam Blackman; Catherine McGregor; Robert Dales; Helen S Driver; Ilya Dumov; Jon Fleming; Kristin Fraser; Charlie George; Atul Khullar; Joe Mink; Murray Moffat; Glendon E Sullivan; John A Fleetham; Najib Ayas; T Douglas Bradley; Michael Fitzpatrick; John Kimoff; Debra Morrison; Frank Ryan; Robert Skomro; Frederic Series; Willis Tsai
Journal:  Can Respir J       Date:  2010 Sep-Oct       Impact factor: 2.409

9.  APAP impact on metabolic syndrome in obstructive sleep apnea patients.

Authors:  Patrícia Caetano Mota; Marta Drummond; João Carlos Winck; Ana Cristina Santos; João Almeida; José Agostinho Marques
Journal:  Sleep Breath       Date:  2010-09-24       Impact factor: 2.816

10.  Accuracy of the clinical parameters and oximetry to initiate CPAP in patients with suspected obstructive sleep apnea.

Authors:  Carlos Alberto Nigro; Eduardo Dibur; Edgardo Rhodius
Journal:  Sleep Breath       Date:  2011-10-14       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.